Argyle Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.56M | Sell |
62,816
-700
| -1% | -$80.8K | 2.46% | 6 |
|
|
2025
Q4 | $6.69M | Buy |
63,516
+3,650
| +6% | +$343K | 2.23% | 8 |
|
|
2025
Q3 | $5.02M | Buy |
59,866
+565
| +1% | +$46.5K | 1.74% | 13 |
|
|
2025
Q2 | $4.69M | Sell |
59,301
-300
| -0.5% | -$23.8K | 1.7% | 12 |
|
|
2025
Q1 | $5.35M | Buy |
59,601
+1,486
| +3% | +$139K | 1.99% | 9 |
|
|
2024
Q4 | $5.78M | Buy |
58,115
+4,467
| +8% | +$461K | 2.28% | 6 |
|
|
2024
Q3 | $6.09M | Sell |
53,648
-3,075
| -5% | -$365K | 2.43% | 6 |
|
|
2024
Q2 | $7.02M | Sell |
56,723
-3,685
| -6% | -$475K | 2.89% | 4 |
|
|
2024
Q1 | $7.97M | Sell |
60,408
-2,102
| -3% | -$259K | 3.08% | 3 |
|
|
2023
Q4 | $6.81M | Sell |
62,510
-9,225
| -13% | -$958K | 2.82% | 3 |
|
|
2023
Q3 | $7.39M | Sell |
71,735
-120
| -0.2% | -$12.9K | 2.71% | 3 |
|
|
2023
Q2 | $8.29M | Sell |
71,855
-2,968
| -4% | -$337K | 2.99% | 3 |
|
|
2023
Q1 | $7.96M | Sell |
74,823
-1,501
| -2% | -$162K | 2.8% | 3 |
|
|
2022
Q4 | $8.47M | Sell |
76,324
-1,490
| -2% | -$152K | 2.91% | 3 |
|
|
2022
Q3 | $6.7M | Sell |
77,814
-175
| -0.2% | -$15.6K | 2.61% | 3 |
|
|
2022
Q2 | $7.11M | Buy |
77,989
+262
| +0.3% | +$23.2K | 2.55% | 4 |
|
|
2022
Q1 | $6.38M | Sell |
77,727
-6,365
| -8% | -$502K | 2.08% | 7 |
|
|
2021
Q4 | $6.45M | Hold |
84,092
| – | – | 2.01% | 8 |
|
|
2021
Q3 | $6.32M | Sell |
84,092
-35
| -0% | -$2.66K | 2.09% | 7 |
|
|
2021
Q2 | $6.54M | Sell |
84,127
-4,075
| -5% | -$303K | 2.11% | 5 |
|
|
2021
Q1 | $6.49M | Hold |
88,202
| – | – | 2.19% | 6 |
|
|
2020
Q4 | $6.88M | Sell |
88,202
-1,033
| -1% | -$79K | 2.56% | 2 |
|
|
2020
Q3 | $7.06M | Sell |
89,235
-2,200
| -2% | -$172K | 2.89% | 3 |
|
|
2020
Q2 | $6.75M | Sell |
91,435
-283
| -0.3% | -$21.3K | 2.83% | 3 |
|
|
2020
Q1 | $6.73M | Sell |
91,718
-220
| -0.2% | -$17.3K | 3.18% | 2 |
|
|
2019
Q4 | $7.98M | Sell |
91,938
-943
| -1% | -$77.5K | 2.83% | 2 |
|
|
2019
Q3 | $7.46M | Sell |
92,881
-1,782
| -2% | -$143K | 2.82% | 2 |
|
|
2019
Q2 | $7.57M | Sell |
94,663
-1,215
| -1% | -$93K | 2.87% | 2 |
|
|
2019
Q1 | $7.61M | Sell |
95,878
-170
| -0.2% | -$12.7K | 2.92% | 2 |
|
|
2018
Q4 | $7M | Sell |
96,048
-1,258
| -1% | -$88.8K | 2.97% | 2 |
|
|
2018
Q3 | $6.59M | Sell |
97,306
-105
| -0.1% | -$6.69K | 2.47% | 3 |
|
|
2018
Q2 | $5.64M | Sell |
97,411
-419
| -0.4% | -$23.6K | 2.24% | 4 |
|
|
2018
Q1 | $5.08M | Sell |
97,830
-2,305
| -2% | -$124K | 2.02% | 8 |
|
|
2017
Q4 | $5.38M | Buy |
100,135
+4,663
| +5% | +$259K | 2.01% | 6 |
|
|
2017
Q3 | $5.83M | Sell |
95,472
-2,684
| -3% | -$163K | 2.29% | 3 |
|
|
2017
Q2 | $6M | Sell |
98,156
-157
| -0.2% | -$9.56K | 2.44% | 2 |
|
|
2017
Q1 | $5.96M | Sell |
98,313
-209
| -0.2% | -$12.7K | 2.43% | 2 |
|
|
2016
Q4 | $5.53M | Sell |
98,522
-2,118
| -2% | -$124K | 2.35% | 2 |
|
|
2016
Q3 | $5.99M | Sell |
100,640
-236
| -0.2% | -$13.8K | 2.6% | 2 |
|
|
2016
Q2 | $5.54M | Sell |
100,876
-131
| -0.1% | -$6.97K | 2.35% | 4 |
|
|
2016
Q1 | $5.1M | Sell |
101,007
-503
| -0.5% | -$24.6K | 2.32% | 4 |
|
|
2015
Q4 | $5.12M | Sell |
101,510
-524
| -0.5% | -$26.4K | 2.36% | 5 |
|
|
2015
Q3 | $4.81M | Buy |
102,034
+1,460
| +1% | +$77.6K | 2.35% | 4 |
|
|
2015
Q2 | $5.46M | Sell |
100,574
-779
| -0.8% | -$43.7K | 2.5% | 3 |
|
|
2015
Q1 | $5.56M | Sell |
101,353
-1,426
| -1% | -$80.7K | 2.49% | 3 |
|
|
2014
Q4 | $5.57M | Sell |
102,779
-923
| -0.9% | -$51.4K | 2.44% | 4 |
|
|
2014
Q3 | $5.87M | Sell |
103,702
-173
| -0.2% | -$9.71K | 2.7% | 1 |
|
|
2014
Q2 | $5.73M | Sell |
103,875
-326
| -0.3% | -$17.8K | 2.67% | 1 |
|
|
2014
Q1 | $5.64M | Sell |
104,201
-1,648
| -2% | -$85.3K | 2.77% | 1 |
|
|
2013
Q4 | $5.05M | Sell |
105,849
-592
| -0.6% | -$27.1K | 2.54% | 3 |
|
|
2013
Q3 | $4.83M | Hold |
106,441
| – | – | 2.65% | 2 |
|
|
2013
Q2 | $4.72M | Buy |
+106,441
| New | +$4.75M | 2.7% | 3 |
|
Other funds holding MRK
VCM
VPM
Argyle Capital Management's MRK Position: Q1 2026 in Review
Argyle Capital Management reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $80.8K and leaving 62,816 shares worth $7.56M. The position accounts for 2.46% of the portfolio, ranked #6.
Argyle Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.47M in Q4 2022. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Argyle Capital Management held 62,816 shares of Merck worth $7.56M as of Q1 2026.
- Argyle Capital Management sold 700 Merck shares in Q1 2026, an estimated $80.8K.
- Merck made up 2.46% of Argyle Capital Management's portfolio in Q1 2026, its #6 holding.
- Argyle Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Argyle Capital Management's Merck position peaked at $8.47M in Q4 2022.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.